Grace Therapeutics (GRCE) Common Equity (2017 - 2026)
Grace Therapeutics (GRCE) recorded Common Equity of $48.21 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 24.1% from $63.55 million a year earlier and down 24.5% from the prior quarter.
Powered by 
Analysis
Grace Therapeutics (GRCE) Common Equity (2017 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Grace Therapeutics reported Common Equity of $63.9 million, down 4.1% from FY2025.
- Annual Common Equity has a five-year compound annual growth rate of 2.8% (FY2021 to FY2026).
- Across earlier fiscal years, Common Equity came in at $66.61 million in FY2025 (+7.9%), $61.74 million in FY2024 (-9.1%), $67.96 million in FY2023 (-37.2%) and $108.27 million in FY2022 (+94.5%).
- The fiscal Q1 2027 figure is the lowest quarterly Common Equity since fiscal Q3 2021.
- On a year-over-year basis, Common Equity rose in four of the last eight quarters, with an average decline of 1.5%.
- Peak year-over-year performance for Common Equity in the last five years was growth of 331.9% in fiscal Q3 2022, against a decline of 38.7% in fiscal Q1 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $63.9 million (Q4 2026), $64.89 million (Q3 2026) and $62.82 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Grace Therapeutics | 34.02 Mn | -32.25 Mn | - | 48.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48.21 Mn |
| Mar 31, 2026 | 63.90 Mn |
| Dec 31, 2025 | 64.89 Mn |
| Sep 30, 2025 | 62.82 Mn |
| Jun 30, 2025 | 63.55 Mn |
| Mar 31, 2025 | 66.61 Mn |
| Dec 31, 2024 | 52.14 Mn |
| Sep 30, 2024 | 56.13 Mn |
| Jun 30, 2024 | 59.36 Mn |
| Mar 31, 2024 | 61.74 Mn |
| Dec 31, 2023 | 64.68 Mn |
| Sep 30, 2023 | 66.75 Mn |
| Jun 30, 2023 | 64.01 Mn |
| Mar 31, 2023 | 67.96 Mn |
| Dec 31, 2022 | 96.72 Mn |
| Sep 30, 2022 | 100.16 Mn |
| Jun 30, 2022 | 104.40 Mn |
| Mar 31, 2022 | 108.27 Mn |
| Dec 31, 2021 | 111.06 Mn |
| Sep 30, 2021 | 114.20 Mn |
API Access
Grace Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();